Inventor · disambiguated record
Jeffrey Mckie
Also filed as: MCKIE JEFFREY · MCKIE JEFFREY A
10 granted patents·3 pending applications·201 citations·filing 2000–2008
90Inventor score
Technology areasA61P
Top patents by PatentIndex Score
13 records- 0191US6331562B1Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2000·Granted Dec 18, 2001·63 cites·63 claims
- 0291US6291456B1Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2000·Granted Sep 18, 2001·62 cites·78 claims
- 0387US6436923B1Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2000·Granted Aug 20, 2002·26 cites·50 claims
- 0486US6620838B1Benzopyrazone compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM INC·Filed 2002·Granted Sep 16, 2003·24 cites·33 claims
- 0580US6372739B1Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2001·Granted Apr 16, 2002·13 cites·20 claims
- 0677US7358274B2Methods for treating or preventing cancer using Benzopyranone CompoundsSIGNAL PHARM LLC·Filed 2006·Granted Apr 15, 2008·2 cites·11 claims
- 0773US7091235B2Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancerSIGNAL PHARM LLC·Filed 2003·Granted Aug 15, 2006·5 cites·11 claims
- 0872US7247646B2Benzopyranone compounds, compositions thereof, and methods of treatment therewithNOVARTIS AG·Filed 2004·Granted Jul 24, 2007·6 cites·4 claims
- 0961US7589119B2Methods for treating or preventing metastatic cancer using benzopyranone compoundsSIGNAL PHARMACEUTICAL LLC·Filed 2008·Granted Sep 15, 2009·0 cites·14 claims
- 1053US7279489B2Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM LLC·Filed 2003·Granted Oct 9, 2007·0 cites·7 claims
- 1148US2004092572A1Benzopyranone compounds, compositions thereof, and methods of treatment therewithFiled 2003·Application pending·0 cites
- 1246US2008242694A1Amino-substituted heterocycles, compositions thereof, and methods of treatment therewithD SIDOCKY NEIL R·Filed 2007·Application pending·0 cites
- 1344US2007015817A14-((4-(2-pyrrolidinylethoxy)phenyl)methyl)-3-(4-(trifluoromethyl)phenyl)-7-hydroxychromen-2one, pharmaceutically acceptable salts thereof and methods of use therewithMCKIE JEFFREY A·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →